Table 3.

Analyses of systolic blood pressure.

Trials		MD [95% CI]	P Value
YQG plus valsartan versus valsartan	1	−7.30 [−10.25, −4.35]	<0.00001
YQG plus antihypertensive drugs versus antihypertensive drugs	1	−9.00 [−10.45, −7.55]	<0.00001
YQG plus antihypertensive drugs versus antihypertensive drugs	1	−4.90 [−7.10, −2.70]	<0.0001
YQG plus indapamide versus indapamide	1	−4.38 [−8.28, −0.48]	0.03
YQG plus antihypertensive drugs versus antihypertensive drugs	1	−16.00 [−17.66, −14.34]	<0.00001
YQG plus antihypertensive drugs versus antihypertensive drugs	1	−1.85 [−4.00, 0.30]	0.09
Meta-analysis	6	−7.31 [−11.75, −2.87]	0.001